Mark L Solter

Years Active: 2021-2021
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Neil H Segal, Andrea Cercek, Geoffrey Y Ku, Abraham Jing-Ching Wu, Andreas Rimner, Danny N Khalil, Diane Reidy-Lagunes, John Cuaron, T Jonathan Yang, Martin R Weiser, Paul B Romesser, Zsofia K Stadler, Marjorie G Zauderer, Karuna Ganesh, Rona Yaeger, Louise C Connell, David M Faleck, Ghassan K Abou-Alfa, Kathleen C Mcauliffe, Pamela Vaiskauskas, Mark L Solter, Martinique Ogle, Matthew J Adamow, Aliya Holland, Pallavi Vedantam, Phillip Wong, Taha Merghoub, Efsevia Vakiani, Travis J Hollmann, Krishna Juluru, Joanne F Chou, Marinela Capanu, Joseph Erinjeri, Stephen Solomon, Yoshiya Yamada, Nancy Kemeny, Christopher H Crane, Leonard B Saltz
Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair-proficient Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (8) (2021)

Mark L Solter.css-eqlu8i{font-size:small;padding-left:4px;}